Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM

Amyloid Pathology Transmission in Lab Mice and Historic Medical Treatments

Read more

Blink' and You Won't Miss Amyloids: Engineering Team Just Found New Way to See Proteins That Cause Alzheimer's, Other Diseases

Read more

Amyloid Assemblies Once Believed to be Toxic Found to Play Key Role in Muscle Generation

Read more

US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy

Read more

Eidos Therapeutics Initiates ATTRibute-CM, a Phase 3 Study of AG10 in ATTR-CM with Registrational 12-month Endpoint

Read more

Subscribe to